Selecting Evidence-Based HIV Prevention Behavioral Interventions for HIV-Negative Persons for National Dissemination

AIDS and Behavior
Charles B CollinsJonathan Mermin

Abstract

This paper describes the development of a formula to determine which evidence-based behavioral interventions (EBIs) targeting HIV-negative persons would be cost-saving in comparison to the lifetime cost of HIV treatment and the process by which this formula was used to prioritize those with greatest potential impact for continued dissemination. We developed a prevention benefit index (PBI) to rank risk-reduction EBIs for HIV-negative persons based on their estimated cost for achieving the behavior change per one would-be incident infection of HIV. Inputs for calculating the PBI included the mean estimated cost-per-client served, EBI effect size for the behavior change, and the HIV incidence per 100,000 persons in the target population. EBIs for which the PBI was ≤ $402,000, the estimated lifetime cost of HIV care, were considered cost-saving. We were able to calculate a PBI for 35 EBI and target population combinations. Ten EBIs were cost-saving having a PBI below $402,000. One EBI did not move forward for dissemination due to high start-up dissemination costs. DHAP now supports the dissemination of 9 unique EBIs targeting 13 populations of HIV-negative persons. The application of a process, such as the PBI, may assist other he...Continue Reading

References

Nov 4, 1992·JAMA : the Journal of the American Medical Association·UNKNOWN Evidence-Based Medicine Working Group
Nov 1, 1992·American Journal of Public Health·J A KellyM G Morgan
Aug 1, 1996·American Journal of Public Health·S M KegelesT J Coates
Jun 5, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·James W DilleyWilli McFarland
May 30, 2003·American Journal of Public Health·Nabila El-BasselPeter Steinglass
Jul 2, 2003·Nature Medicine·Ronald O ValdiserriEugene McCray
Aug 28, 2003·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Carl A LatkinAmy Knowlton
Aug 28, 2003·Prevention Science : the Official Journal of the Society for Prevention Research·Mary Jane Rotheram-BorusCheryl Koopman
Oct 31, 2003·AIDS and Behavior·Scott L HershbergerDennis G Fisher
Mar 5, 2004·American Journal of Public Health·Cesar G VictoraJennifer Bryce
Jul 14, 2004·JAMA : the Journal of the American Medical Association·Ralph J DiClementeAlyssa Robillard
Sep 27, 2005·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Leslie F ClarkSnigdha Mukherjee
Mar 3, 2006·AIDS·Nicole CrepazUNKNOWN HIV/AIDS Prevention Research Synthesis (PRS) Team
Aug 9, 2006·Archives of Pediatrics & Adolescent Medicine·Antonia M VillarruelLoretta S Jemmott
Sep 22, 2006·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Charles CollinsMyriam Hamdallah
Sep 22, 2006·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Cynthia M LylesUNKNOWN HIV/AIDS Prevention Research Synthesis Team
Dec 2, 2006·American Journal of Public Health·Cynthia M LylesUNKNOWN HIV/AIDS Prevention Research Synthesis Team
Dec 19, 2007·Administration and Policy in Mental Health·Sonja K SchoenwaldUNKNOWN Research Network on Youth Mental Health
May 1, 2008·American Journal of Public Health·Kenneth T JonesWayne D Johnson
Jul 18, 2009·American Journal of Public Health·Ross C BrownsonKatherine A Stamatakis
Jul 14, 2010·Archives of Internal Medicine·Nabila El-BasselUNKNOWN NIMH Multisite HIV/STD Prevention Trial for African American Couples Group
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Jan 5, 2011·Administration and Policy in Mental Health·Gregory A AaronsSarah McCue Horwitz
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Jan 15, 2014·AIDS and Behavior·Lydia O'DonnellStephen Flores

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.